You Position: Home > Paper

Research progress on correlations between interlukin-28B polymorphism and hepatitis B

( views:184, downloads:188 )
Author:
No author available
Journal Title:
Chinese Journal of Clinical Infectious Diseases
Issue:
1
DOI:
10.3760/cma.j.issn.1674-2397.2015.01.020
Key Word:
肝炎,乙型,慢性;白介素-28B;基因多态性;干扰素类;Hepatitis B,chronic;Interlukin-28B;Gene polymorphism;Interferons

Abstract: Interferon (IFN) is one of the commonly used anti-HBV drug in clinic,in which IFN-λ is a new type of IFN,including IFN-λ1,IFN-λ2 and IFN-λ3 (also called IL-29,IL-28A and IL-28B,respectively).Researches in recent years show that IFN-λ3 (IL-28B) polymorphism seems to be involved in the onset of hepatitis B,the response to antiviral therapy and the outcome of HBV infection.This paper reviews the correlations between IL-28B polymorphism and the spontaneous clearance of HBV,the progression of HBV infection,the occurrence of liver cancer and the therapeutic effect of IFN treatment.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn